PKO Biotech & Innovation Global is oriented towards a sector of companies engaged in research and development in the area of natural science and technology, including chemicals, electronics, healthcare, pharmaceuticals and bio- and nanotechnology. This offer will be perfect for investors wishing to increase their capital effectively, using the growth potential of innovative/biotechnological equities.
The subfund is directed at customers who:
67 1030 1508 0000 0008 0497 1017
Direct payments may be made for persons holding at least one active register in PKO funds
At least 70% of the Subfund’s Net Asset Value will be constituted jointly by:
a) equities of companies engaged primarily in research and development in the area of natural science and technology, including chemicals, electronics, healthcare, pharmaceuticals and bio- and nanotechnology, as well as other related sectors of the economy.
b) investment certificates, fund participation units or participation titles of institutions of common investment, if their investment policy aims at reflecting the components of an innovations and biotechnology equity index.
At least 30% of the Subfund’s Net Asset Value will be constituted by debt securities.
